As many of my readers know, the current “standard of care” for treating conditions such as schizophrenia are anti-psychotic drugs, most of which are potent dopamine antagonists. One of the main side effects of taking such drugs is elevated prolactin (dopamine and prolactin oppose each other), which is another way of saying that dopamine antagonists are estrogenic. One of the symptoms of excess estrogen is repetitive, uncontrollable movements clinically known as chorea, as well as parkinsonism (due to the dopamine antagonism of the drugs). The family of chorea-like symptoms are ubiquitous in people taking anti-psychotic drugs. Mainstream medicine claims that such side effects not only cannot be addressed effectively, but are often permanent and irreversible. The study below demonstrates striking reductions (80%+) of those chorea-like symptoms in a patient using anti-psychotic drugs after 3 weeks of taking 400 IU vitamin E daily, and after that patient failed to respond to all other therapies. This is yet another confirmation of the anti-estrogenic effects of vitamin E, which were well-known and publicized up until the 1950s when mass estrogenic therapy was embraced by medicine and all natural anti-estrogenic substances were quickly “cancelled” from both the medical literature and clinical practice. Nowadays, if vitamin E is mentioned at all, it is always as an anti-oxidant and never as an endocrine modulator (e.g. progestogenic and anti-estrogenic).
“…Antipsychotic medications, while crucial in managing severe psychiatric disorders such as schizophrenia and bipolar disorder, are frequently associated with extrapyramidal symptoms (EPS) and tardive dyskinesia (TD). TD, characterized by repetitive, involuntary movements, especially of the face and limbs, poses a substantial clinical challenge due to its often irreversible nature. Conventional management strategies, including dose reduction and switching to atypical antipsychotics, frequently offer limited success, prompting exploration of alternative therapies. This case report highlights the effectiveness of vitamin E, a potent antioxidant, in treating a 28-year-old male with severe antipsychotic-induced EPS and TD, unresponsive to traditional therapies. The patient, who had been receiving paliperidone injections as part of his psychotic disorder treatment regimen, developed marked EPS, including muscle rigidity, a parkinsonian gait, significant motor disturbances as well as tardive dyskinesia. Despite discontinuation of paliperidone and initiation of procyclidine, propranolol, clonazepam, and omega-3 supplements, his symptoms persisted. Introduction of oral vitamin E at 400 IU daily led to a dramatic improvement, with an 80% reduction in EPS and TD symptoms within weeks.”
